13/08/2026
A public health crisis with global ripples
The executive order signed by US President Donald Trump on August 10, 2026, marks a significant and deeply concerning shift in American childhood vaccination policy. By slashing the number of routinely recommended vaccines from 18 to 11, calling for the separation of the combined MMR vaccine, and encouraging states to relax school-entry requirements, the order undermines decades of established scientific evidence and public health practice. https://theconversation.com/why-trumps-mmr-vaccine-order-is-the-latest-public-health-disaster-with-effects-set-to-last-years-289479?utm_source=twitter&utm_medium=bylinetwitterbutton
While the order does not ban vaccines, it lends credibility to scientifically unfounded notions of vaccine risk, including the debunked link to autism. Public health experts, including the World Health Organisation, have voiced alarm, warning that such changes could lead to delays in vaccination, reduce overall coverage, and trigger outbreaks of preventable diseases like measles, which is already on the rise in the US and globally.
The potential for damage extends far beyond America's borders, threatening global health security through the disruption of international aid and the weakening of key health institutions.
Ramifications for Australia
For Australia, the consequences of this order are both direct and indirect:
One impact is potential increased exposure to infectious diseases. As a nation heavily reliant on international travel, Australia is directly exposed to global disease outbreaks. The resurgence of measles in the US and other regions creates a higher risk of imported cases, a threat Australia is already grappling with as 2026 cases have surpassed those of the same period in 2025. A less vaccinated global population increases the probability of travellers introducing the virus, putting pressure on Australia's own vaccination coverage, which is already slipping below the 95% herd immunity threshold.
Another impact is weakening of health and medicine supply chains. Australia has long relied on US health institutions like the FDA and NIH for drug approvals and biomedical research. The hollowing out of these agencies threatens the pipeline for new medicines and could disrupt access to vital therapies. Furthermore, the Trump administration's "most favoured nation" pricing policies and 100% tariffs on pharmaceuticals directly target Australia's Pharmaceutical Benefits Scheme (PBS), placing pressure on affordability and availability of medicines. This creates significant uncertainty for the Australian health system's ability to provide equitable access to essential drugs.
A third issues is erosion of the global health framework. The US withdrawal from the World Health Organisation and the disruption of its foreign aid programs will cripple global efforts to control diseases like HIV, tuberculosis, and malaria. The breakdown of the international health surveillance and response network, which has been a cornerstone for protecting Australia from emerging global health threats, leaves Australia more vulnerable and potentially forces a more costly, independent response in the future.
Trump’s latest executive order is set to lead to delayed vaccinations, falling coverage and a resurgence of diseases once brought under control.